Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Korbel Gregory Alan
SVP, Chief Business Officer at Aprea Therapeutics. Filing since 7 Oct 2019.
CIK 0001789032
Company
Date
Role
Action
Shares
Amount
Of holding
APRE
Aprea Therapeutics, Inc.
1 Dec 2021
SVP, Chief Business Officer
Sold, plan not stated
27,500
$108.90K
61.6%
APRE
Aprea Therapeutics, Inc.
1 Nov 2021
SVP, Chief Business Officer
Sold, plan not stated
27,500
$137.50K
61.6%
APRE
Aprea Therapeutics, Inc.
1 Oct 2021
SVP, Chief Business Officer
Sold, plan not stated
27,500
$134.48K
61.6%
APRE
Aprea Therapeutics, Inc.
20 Sep 2021
SVP, Chief Business Officer
Sold, plan not stated
32,960
$163.87K
65.8%
APRE
Aprea Therapeutics, Inc.
7 Oct 2019
VP of Business Dev't
Bought
500
$7.50K
opened
5 decisions on file.
